- Uboldi C, Tassistro V, Rober S, Dussert F, Carrière M and Orsière T. Development of a new test to assess the mutagenic potential of nanomaterials: the in vitro PIG-A assay. 47th European Environmental Mutagenesis and Genomics Society Meeting (19-23 mai 2019; Rennes, France).
- Uboldi C, Bernard E, George I, Sanles M, Roche S, Magdinier F, Rousseau B, Dinescu G, Herlin N, Lebaron-Jacobs L, Delaporte P, Vrel D, Rose J, Malard V, Grisolia C and Orsière T. Tritiated and non tritiated ITER-like tungsten particles in lung-derived cells: an epigenotoxic study. First Tritium School – TRANSAT H2020 project (25-28 Mars 2019; Ljubljana, Slovenie).
- Uboldi C, Dussert F, Tassistro V, Carrière M, Orsière T. Mutagénèse induite par les nanoparticules: criblage du test PIG-A in vitro sur l’Homme. Forum annuel de la Société Française de Toxicologie Génétique (1-2 octobre 2018; Paris, France).
- Uboldi C, Bernard E, George I, Sanles M, Roche S, Magdinier F, Rousseau B, Dinescu G, Herlin N, Lebaron-Jacobs L, Delaporte P, Vrel D, Rose J, Malard V, Grisolia C and Orsière T. Epigenotoxic investigation of tritiated and non tritated ITER-like tungsten particles in lung-derived cells: the PASSIV-ITER project. 11th International Particle Toxicology Conference (26-29 septembre 2016; Singapour).
- Uboldi C, Bernard E, George I, Sanles M, Roche S, Magdinier F, Rousseau B, Dinescu G, Herlin N, Lebaron-Jacobs L, Delaporte P, Vrel D, Rose J, Malard V, Grisolia C and Orsière T. ITER-like tritiated tungsten particles: cytotoxic and genotoxic effects in lung cells. Forum annuel de la Société Française de Toxicologie Génétique (23-24 juin 2016; Paris, France).
- Uboldi C, Bernard E, George I, Sanles M, Roche S, Magdinier F, Rousseau B, Dinescu G, Herlin N, Lebaron-Jacobs L, Delaporte P, Vrel D, Rose J, Malard V, Grisolia C and Orsière T. ITER-like tritiated tungsten particles: cytotoxic and genotoxic effects in lung cells. Journée Annuelle « Faits Marquants et Perspectives » du programme transversal Toxicologie du Commissariat à l’énergie atomique et aux énergies alternatives (CEA) (22 juin 2016; CEA Saclay, Gif-sur-Yvette, France).
- Uboldi C, Di Bucchianico S, Brunetti T, Luongo S., Coppedè F., Delpivo C., Costa A., Migliore L. A panel of tests to evaluate genotoxicity and carcinogenicity induced in vitro by metal oxide nanoparticles. XIII Congress of the Italian Federation of Life Sciences (24-27 septembre 2014; Pise, Italie).
- Kinsner-Ovaskainen A, Uboldi C, Cydzik I, Simonelli F, Alloa E, Ceridono M, Gilliland D, Ponti J, Rossi F. Assessment of cytotoxicity, intracellular uptake and intestinal absorption of amorphous silica nanoparticles in the Caco-2 in vitro human intestinal barrier model. NanoSafe 2012 (13-15 novembre 2012; Grenoble, France).
- Farcal LR, Uboldi C, Mehn D, Giudetti G, Nativo P, Ponti J, Gilliland D, Rossi F and Bal-Price A. The response of an in vitro human alveolar barrier to SiO2 nanoparticles exposure in the presence or absence of THP-1 monocytes. 9th International Conference and Workshop on Biological Barriers (29 février – 3 mars 2012; Sarrebruck, Allemagne).
- Uboldi C, Giudetti G, Broggi F, Ponti J, Gilliland D, and Rossi F. Assessment of the in vitro toxicological profile of amorphous silica nanoparticles and study of their intracellular fate. CELLTOX 1991-2011 Twenty years of in vitro toxicology: Achievements and future challenges (19-21 octobre 2011; Rome, Italie).
- Uboldi C, Giudetti G, Broggi F, Ponti J, Gilliland D, and Rossi F. Assessment of the in vitro toxicological profile of amorphous silica nanoparticles and study of their intracellular fate. SPP1313 Biological Responses to Nanoscale Nanoparticles (11-15 septembre 2011; Essen, Allemagne).
- Uboldi C, Ponti J, Giudetti G, Gilliland D, Rossi F, Calzolai L. Use of fluorescent amorphous silica to study the intracellular fate of nanoparticles and assessment of its in vitro toxicological profile. ICMAT - International Conference on Materials for Advanced Technologies (26 juin - 01 juillet 2011; Singapour).
- Uboldi C, Ponti J, Gilliland D, and Rossi F. Evaluation of the toxicity of manufactured nanomaterials by in vitro methods. 1st Italian-Swedish Workshop on Health Impacts of Engineered Nanoparticles (14-15 octobre 2010; Rome, Italie).
- Uboldi C. Nanoparticles-induced cytotoxicity in human alveolar cells. Invitée chez F.Hoffman-Roche (27 avril 2009; Bâle, Suisse).
- Uboldi C. Interaction of nanoparticles with an in vitro model of the human alveolo-capillary barrier. Invitée à l’Institut de biologie du poumon et Centre pour la recherche translationnelle du poumon, Helmholtz Zentrum (14 avril 2009; Munich, Allemagne).
- Uboldi C. Methods to assess nanoparticle uptake and traffic in cells. CellNanoTox 1st interdisciplinary workshop on novel methodologies for studying nanoparticles and their interaction with biomaterials (14 avril 2008; Ludwigshafen, Allemagne).
- Uboldi C, Hermanns I, Pohl C, Kirkpatrick CJ. In vitro co-culture models of the human proximal and distal respiratory unit. Centre for Nanotechnology (3 juin 2007; Münster, Allemagne).
- Uboldi C, Hermanns I, Kirkpatrick CJ. Co-culture models of the bronchial and air-blood barrier to study nanoparticles interaction. 3rd Nano2Life Conference (19-21 mars 2007; Sarrebruck, Allemagne).
- Uboldi C, Siegelman M, Engelhardt B. L-selectin-deficient mice develop experimental autoimmune encephalomyelitis. 3rd International Summer school in Immunology (14-16 août 2004; Champéry, Suisse).
